Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients
Julia Vistbakka, Marja‐Liisa Sumelahti, Terho Lehtimäki, et al.
Acta Neurologica Scandinavica (2018) Vol. 138, Iss. 2, pp. 130-136
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression
PhilipV Peplow, Bridget Martinez
Neural Regeneration Research (2019) Vol. 15, Iss. 4, pp. 606-606
Open Access | Times Cited: 79
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases
T. P. Nhung Nguyen, Mandeep Kumar, Ernesto Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4718-4718
Open Access | Times Cited: 55
Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications
Yanjun Zhang, Lijuan Zhan, Xue Jiang, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116218-116218
Closed Access | Times Cited: 15
MicroRNA in multiple sclerosis
Yan Gao, Dong Han, Juan Feng
Clinica Chimica Acta (2021) Vol. 516, pp. 92-99
Closed Access | Times Cited: 46
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis
Georgia Mandolesi, Francesca Romana Rizzo, Sara Balletta, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 330-330
Open Access | Times Cited: 30
Remyelination in multiple sclerosis from the miRNA perspective
Karina Maciak, Angela Dziedzic, Joanna Saluk
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 11
Hypoxia-induced miR-191-C/EBPβ signaling regulates cell proliferation and apoptosis of fibroblast-like synoviocytes from patients with rheumatoid arthritis
Shanshan Yu, Ying Lü, Ming Zong, et al.
Arthritis Research & Therapy (2019) Vol. 21, Iss. 1
Open Access | Times Cited: 32
MicroRNA-191 blocking the translocation of GLUT4 is involved in arsenite-induced hepatic insulin resistance through inhibiting the IRS1/AKT pathway
Wenqi Li, Lu Wu, Qian Sun, et al.
Ecotoxicology and Environmental Safety (2021) Vol. 215, pp. 112130-112130
Open Access | Times Cited: 24
miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis
Federica Scaroni, Caterina Visconte, María Serpente, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1551-1551
Open Access | Times Cited: 18
Molecular biomarkers, network biomarkers, and dynamic network biomarkers for diagnosis and prediction of rare diseases
Shijie Tang, Kai Yuan, Luonan Chen
Fundamental Research (2022) Vol. 2, Iss. 6, pp. 894-902
Open Access | Times Cited: 17
Enhanced expression of miR-128 in peripheral blood mononuclear cells: a potent candidate diagnostic biomarker for multiple sclerosis
Hossein Akhgari, Alireza Ahmadi, Abedeh Rezaei, et al.
Neurological Research (2025), pp. 1-9
Closed Access
Genomic ncRNAs Regulating Mitochondrial Function in Neurodegeneration: A Neglected Clue in the Complex Etiopathogenesis of Multiple Sclerosis
Nima Sanadgol, Mahedeh Samadi, Clara Voelz, et al.
Research Square (Research Square) (2025)
Closed Access
Differential Expression of miRNAs and Behavioral Change in the Cuprizone-Induced Demyelination Mouse Model
Seung Ro Han, Yun Hee Kang, Hyungtaek Jeon, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 646-646
Open Access | Times Cited: 25
MiRNA-based therapeutic potential in multiple sclerosis
Ana Zabalza, Agustín Pappolla, Manuel Comabella, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
MicroRNA‐191‐5p ameliorates amyloid‐β 1‐40 –mediated retinal pigment epithelium cell injury by suppressing the NLRP3 inflammasome pathway
Jieqiong Chen, Junran Sun, Yifan Hu, et al.
The FASEB Journal (2021) Vol. 35, Iss. 4
Closed Access | Times Cited: 19
Versatile role of miR-24/24-1*/24-2* expression in cancer and other human diseases.
Sanjukta Mukherjee, Bhagyashree Shelar, Sudhir Krishna
PubMed (2022) Vol. 14, Iss. 1, pp. 20-54
Closed Access | Times Cited: 14
An Update on Diagnostic Laboratory Biomarkers for Multiple Sclerosis
Marwa Kaisey, Ghazal Lashgari, Justyna Fert‐Bober, et al.
Current Neurology and Neuroscience Reports (2022) Vol. 22, Iss. 10, pp. 675-688
Closed Access | Times Cited: 14
Exploring the impact of miR-128 in inflammatory diseases: A comprehensive study on autoimmune diseases
Ria Margiana, Hamzah H. Kzar, Fadhil Hussam, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154705-154705
Open Access | Times Cited: 8
Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study
Maria Liguori, Nicoletta Nuzziello, Marta Simone, et al.
Brain and Behavior (2019) Vol. 9, Iss. 2
Open Access | Times Cited: 22
Epigenetics in Multiple Sclerosis
Vera Chan
Advances in experimental medicine and biology (2020), pp. 309-374
Closed Access | Times Cited: 19
Serum Based miRNA as a Diagnostic Biomarker for Multiple Sclerosis: a Systematic Review and Meta-Analysis
Samar Zailaie, Jumana J. Siddiqui, Rawan Mansour Al Saadi, et al.
Immunological Investigations (2021) Vol. 51, Iss. 4, pp. 947-962
Closed Access | Times Cited: 18
miR-24-3p and miR-484 are potential biomarkers for neurodegeneration in multiple sclerosis
Rabeah Al‐Temaimi, Raed Alroughani
Heliyon (2024) Vol. 10, Iss. 12, pp. e32685-e32685
Open Access | Times Cited: 2
MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer’s disease
Wenjun Wan, Ganzhe Liu, Xia Li, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 12678-12690
Open Access | Times Cited: 16
Integrational analysis of miRNAs data sets as a plausible missing linker between Epstein-Barr virus and vitamin D in relapsing remitting MS patients
Majid Teymoori‐Rad, Sayed‐Hamidreza Mozhgani, Mohadeseh Zarei Ghobadi, et al.
Gene (2018) Vol. 689, pp. 1-10
Closed Access | Times Cited: 18
Serum microRNAs in ASD: Association With Monocyte Cytokine Profiles and Mitochondrial Respiration
Harumi Jyonouchi, Lee Geng, Gökçe Törüner, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top